Clinical use of lipids to control inflammatory disease

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 1, Issue 2, 1998, Pages 179-184

  Mayer, Konstantin ^a   Seeger, Werner ^a   Grimminger, Friedrich ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; LIPID;

ANIMAL; DIET SUPPLEMENTATION; ENTERITIS; HUMAN; INFLAMMATION; PATHOPHYSIOLOGY; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SEPSIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, RHEUMATOID; DIETARY SUPPLEMENTS; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; LIPIDS; PSORIASIS; SEPSIS;

EID: 0032009403     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075197-199803000-00006     Document Type: Article

References (70)

1. Caughey GE, Mantzioris E, Gibson RA, Cleland LG, James MJ. The effect on human tumor necrosis factor a and interleukin 1 β production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 1996; 63:116-122.
2. Babu US, Bunning VK, Wiesenfeld P, Raybourne RB, O'Donnell M. Effect of dietary flaxseed on fatty acid composition, superoxide, nitric oxide generation and antilisterial activity of peritoneal macrophages from female Sprague-Dawley rats. Life Sci. 1997; 60:545-554..
3. Halvorsen DS, Hansen J-B, Grimsgaard S, Bonaa KH, Kierulf P, Nordoy A. The effect of highly purified eicosapentaenoic and docosahexaenoic acids on monocyte phagocytosis in man. Lipids 1997; 32:935-942.
4. Mitjavila MT, Rodriguez MC, Saiz MP, Lloret S, Moreno JJ. Effect of degree of unsaturation in dietary fatty acids on arachidonic acid mobilization by peritoneal macrophages. Lipids 1996; 31:661-666.
5. Hughes DA, Southon S, Pinder AC. (N3) Polyunsaturated fatty acids modulate the expression of functionally associated molecules on human monocytes in vitro. J Nutr 1996; 126:603-610.
6. Hughes DA, Pinder AC, Pinder Z, Johnson IT, Lund EK. Fish oil supplementation inhibits the expression of major histocompatibility complex class II molecules and adhesion molecules on human monocytes. Am J Clin Nutr 1996; 63:267-272.
7. Pietsch A, Weber C, Goretzki M, Weber PC, Lorenz RL. N-3 but not n-6 fatty acids reduce the expression of the combined adhesion and scavenger receptor CD36 in human monocytic cells. Cell Biochem Funct 1995; 13:211-216.
8. DeCaterina R, Cybulsky MI, Clinton SK, Gimbrone MA Jr, Libby P. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb 1994; 14:1829-1836.
9. Weber C, Erl W, Pietsch A, Danesch U, Weber PC. Docosahexaenoic acid selectively attenuates induction of vascular cell adhesion molecule1 and subsequent monocytic cell adhesion to human endothelial cells stimulated by tumor necrosis factor-alpha. Arterioscler Thromb Vasc Biol 1995; 15:622-628.
10. DeCaterina R, Libby P. Control of endothelial leukocyte adhesion molecules by fatty acids. Lipids 1996; 31 (Suppl):S57-S63.
11. Collie-Duguid ESR, Wahle KWJ. Inhibitory effect of fish oil n-3 polyunsaturated fatty acids on the expression of endothelial cell adhesion molecules. Biochem Biophys Res Commun 1996; 220:969-974.
12. Calder PC. Can n-3 polyunsaturated fatty acids be used as immunomodulatory agents? Biochem Soc Trans 1996; 24:211-220.
13. Khalfoun B, Thibault G, Bardos P, Lebranchu Y. Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human lymphocyte endothelial cell adhesion. Transplantation 1996; 62:1649-1657.
14. Calder PC, Bevan SJ, Newsholme EA. The inhibition of T-lymphocyte proliferation by fatty acids is via an eicosanoid-independent mechanism. Immunology 1992; 75:108-115.
15. Vassilopoulos D, Zurier RB, Rosetti RG, Tsokos GC. Gammalinolenic acid and dihomogammalinolenic acid suppress the CD3-mediated signal transduction pathway in human T cells. Clin Immunol Immunopathol 1997; 83:237-244.
16. May CL, Southworth AJ, Calder PC. Inhibition of lymphocyte protein kinase C by unsaturated fatty acids. Biochem Biophys Res Commun 1993; 195:823-828.
17. Wu D, Meydani SN, Meydani M, Hayek MG, Huth P, Nicolosi RJ. Immunologic effects of marine- and plant-derived n-3 polyunsaturated fatty acids in nonhuman primates. Am J Clin Nutr 1996; 63:273-280. This is an interesting study addressing the combined effect of lipid and tocopherol supplementation.
18. Jeffery NM, Cortina M, Newsholme EA, Calder PC. Effects of variations in the proportions of saturated, monounsaturated and polyunsaturated fatty acids in the rat diet on spleen lymphocyte functions. Br J Nutr 1997; 77:805-823.
19. Yagaloff KA, Franco L, Simko B, Burghardt B. Essential fatty acids are antagonists of the leukotriene B4 receptor. Prostaglandins Leukot Essent Fatty Acids 1995; 52:293-297.
20. 2 in myocardium. Mol Cell Biochem 1996; 157:199-210.
21. Sperling RI, Benincaso AI, Knoell CT, Larkin JK, Austen KF, Robinson DR. Dietary omega-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils. J Clin Invest 1993; 91:651-660.
22. Litman BJ, Mitchell DC. A role for phospholipid polyunsaturation in modulating membrane protein function. Lipids 1996; 31 (Suppl):S193-S197.
23. Jolly CA, Jiang YH, Chapkin RS, McMurray DN. Dietary (N 3) polyunsaturated fatty acids suppress murine lymphoproliferation, interleukin 2 secretion, and the formation of diacylglycerol and ceramide. J Nutr 1997; 127:37-43.
24. Slater SJ, Kelly MB, Yeager MD, Larkin J, Ho C, Stubbs CD. Polyunsaturation in cell membranes and lipid bilayers and its effects on membrane proteins. Lipids 1996; 31:8189-8192.
25. Sellmayer A, Danesch U, Weber PC. Effects of different polyunsaturated fatty acids on growth related early gene expression and cell growth. Lipids 1996; 31 (Suppl):S37-S40.
26. Terano T, Shiina T, Tamura Y. Eicosapentaenoic acid suppressed the proliferation of vascular smooth muscle cells through modulation of various steps of growth signals. Lipids 1996; 31 (Suppl):S301-S304.
27. Camandola S, Leonarduzzi G, Musso T, Varesio L, Carini R, Scavazza A, et al. Nuclear factor KB is activated by arachidonic acid but not by eicosapentaenoic acid. Biochem Biophys Res Commun 1996; 229:643-647.
28. Robinson DR, Urakaze M, Huang RY, Taki H, Sugiyama E, Knoell CT, et al. Dietary marine lipids suppress continuous expression of interleukin 1 beta gene transcription. Lipids 1996; 31 (Suppl):S23-S31.
29. Karikó K, Rosenbaum H, Kuo A, Zurier RB, Barnathan ES. Stimulatory effect of unsaturated fatty acids on the level of plasminogen activator inhibitor-1 mRNA in cultured human endothelial cells. FEBS Lett 1995; 361:118-122.
30. Connelly KG, Repine JE. Markers for predicting the development of acute respiratory distress syndrome. Annu Rev Med 1997; 48:429-445.
31. Grimminger F, Wahn H, Mayer K, Kiss L, Walmrath D, Seeger W. Impact of arachidonic versus eicosapentaenoic acid on exotoxin-induced lung vascular leakage: relation to 4-series versus 5-series leukotriene generation. Am J Respir Crit Care Med 1997; 155:513-519.
32. Grimminger F, Mayer K, Kiss L, Wahn H, Walmrath D, Seeger W. Synthesis of 4- and 5-series leukotrienes in the lung microvasculature challenged with Escherichia coli hemolysin: critical dependence on exogenous free fatty acid supply. Am J Respir Cell Mol Biol 1997; 16:317-324.
33. Grimminger F, Mayer K, Krämer H-J, Stevens J, Walmrath D, Seeger W. Differential vasoconstrictor potencies of free fatty acids in the lung vasculature: 2- versus 3-series prostanoid generation. J Pharmacol Exp Ther 1993; 267:259-265.
34. Grimminger F, Wahn H, Kramer HJ, Stevens J, Mayer K, Walmrath D, Seeger W. Differential influence of arachidonic vs. eicosapentaenoic acid on experimental pulmonary hypertension. Am J Physiol 1995; 268:H2252-H2259.
35. Mancuso P, Whelan J, DeMichele SJ, Snider CC, Guszcza JA, Claycombe KJ, et al. Effects of eicosapentaenoic and γ-linolenic acid on lung permeability and alveolar macrophage eicosanoid synthesis in endotoxic rats. Crit Care Med 1997; 25:523-532. Dietary supplementation with GLA and FO results in an improvement of septic lung injury in parallel with decreased eicosanoid formation.
36. Murray MJ, Svingen BA, Holman RT, Yaksh TL. Effects of a fish oil diet on pig's cardiopulmonary response to bacteremia. J Parent Enteral Nutr 1991; 15:152-158.
37. Murray MJ, Svingen BA, Yaksh TL, Holman RT. Effects of endotoxin on pigs prefed omega-3 vs. omega-6 fatty acids-enriched diets? Am J Physiol 1993; 265:E920-E927.
38. Murray MJ, Kumar M, Gregory TJ, Banks PL, Tazelaar HD, DeMichele SJ. Select dietary fatty acids attenuate cardiopulmonary dysfunction during acute lung injury in pigs. Am J Physiol 1995; 269:H2090-H2099.
39. Ziboh VA, Yun M, Hyde DM, Giri SN. Gamma linolenic acid containing diet attenuates bleomycin induced lung fibrosis in hamsters. Lipids 1997; 32:759-767.
40. Thyssen E, Turk J, Bohrer A, Stenson WF. Quantification of distinct molecular species of platelet activating factor in ulcerative colitis. Lipids 1996; 31 (Suppl):S255-S259.
41. Vilaseca J, Salas A, Guarner F, Rodriguez R, Malagelada JR. Participation of thromboxane and other eicosanoid synthesis in the course of experimental inflammatory colitis. Gastroenterology 1990; 98:269-277.
42. Campbell JM, Fahey GC, Lichtensteiger CA, DeMichele SJ, Garleb KA. An enterai formula containing fish oil, indigestible oligosaccharides, gum arabic and antioxidants affects plasma and colonie phospholipid fatty acid and prostaglandin profiles in pigs. J Nutr 1997; 127:137-145.
43. Grisham MB, DeMichele SJ, Garleb KA, Specian RD. Sulfasalazine or enterai diets containing fish oil or oligosaccharides attenuate chronic colitis in rats. Inflam Bowel Dis 1996; 2:178-188.
44. Inui K, Fukuta Y, Ikeda A, Kameda H, Kokuba Y, Sato M. The effect of α-linolenic acid-rich emulsion on fatty acid metabolism and leukotriene generation of the colon in a rat model with inflammatory bowel disease. Ann Nutr Metab 1996; 40:175-182.
45. Inui K, Fukuta Y, Ikeda A, Kameda H, Kokuba Y, Sato M. The nutritional effect of α-linolenic acid-rich emulsion with total parenteral nutrition in a rat model with inflammatory bowel disease. Ann Nutr Metab 1996; 40:227-233.
46. Shoda R, Matsueda K, Yamato S, Umeda N. Epidemiologie analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in japan. Am J Clin Nutr 1996; 63:741-745.
47. Belluzzi A, Brignola C, Campieri M, Camporesi EP, Gionchetti P, Rizzello F, et al. Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients. Dig Dis Sci 1994; 39:2589-2594.
48. Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M. Effect of an enteric-coated fish oil preparation on relapses in Crohn's disease. N Engl J Med 1996; 334:1557-1560. This is an impressive study showing the beneficial effect of the newly developed enteric-coated FO capsules on the relapses of Crohn's disease.
49. Stenson WF, Cort D, Rodgers J, Burakoff R, DeSchryver-Kecskemeti K, Gramlich TL, Beeken W. Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med 1992; 116:609-614.
50. Asian A, Triadafilopoulos G. Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study. Am J Gastroenterol 1992; 87:432-437.
51. Hawthorne AB, Daneshmend TK, Hawkey CJ, Belluzzi A, Everitt SJ, Holmes GK, et al. Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial. Gut 1992; 33:922-928.
52. Loeschke K, Ueberschaer B, Pietsch A, Gruber E, Ewe K, Wiebecke B, et al. N-3 fatty acids only delay early relapse of ulcerative colitis in remission. Dig Dis Sci 1996; 41:2087-2094. The authors show that FO retards early relapses of ulcerative colitis and speculate that there might be an additive effect of FO taken along with 5-aminosalicylic acid.
53. Kremer J. Effects of modulation of inflammatory and immune parameters in patients with rheumatic and inflammatory disease receiving dietary supplementation of n-3 and n-6 fatty acids. Lipids 1996; 31:243-247.
54. Kremer J, Lawrence DA, Petrillo GF, Lifts LL, Mullaly PM, Rynes RI, et al. Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs. Arthritis Rheum 1938; 38:1107-1114.
55. Zurier RB, Rossetti RG, Jacobson EW, DeMarco DM, Liu NY, Temming JE, et al. Gamma-linolenic acid treatment of rheumatoid arthritis. Arthritis Rheum 1996; 39:1808-1817. This large-scale, long-term study on application of GLA in patients with rheumatoid arthritis showed improvement in disease activity.
56. Sanderson P, Yaqoob P, Calder PC. Effects of dietary lipid manipulation upon grafts vs host and host vs graft responses in the rat. Cell Immunol 1995; 164:240-247.
57. Jeffery NM, Sanderson P, Sherrington EJ, Newsholme EA, Calder PC. The ratio of n-6 to n-3 polyunsaturated fatty acids in the rat diet alters serum lipid levels and lymphocyte functions. Lipids 1996; 31:737-745.
58. Kwansong K, Nosaka S, Hashimoto M, Kin S, Saitoh Y, Alam MS, et al. The effects of co-3 polyunsaturated fatty acids on the recovery of cardiac function following cold preservation and reperfusion in hyperlipidemic rats. Transplantation 1996; 62:735-742.
59. Grimminger F, Grimm H, Führer D, Papavassilis C, Lindemann G, Blecher C, et al. ω-3 Lipid infusion in a heart allotransplant model. shift in fatty acid and lipid mediator profiles and prolongation of transplant survival. Circulation 1996; 93:365-371.
60. Van der Heide JJH, Bilo HJG, Donker JM, Wilmink JM, Tegzess AM. Effect of dietary fish oil on renal function and rejection in cyclosporine-treated recipients of renal transplants. N Engl J Med 1993; 329:769-773.
61. Bennett WM, Carpenter CB, Shapiro ME, Strom TB, Hefty D, Tillman M, et al. Delayed omega-3 fatty acid supplements in renal transplantation: a double-blind, placebo controlled study. Transplantation 1995; 1995; 59:352-356.
62. Andreassen AK, Hartmann A, Offstad J, Geiran O, Kvernebo K, Simonsen S. Hypertension prophylaxis with omega 3 fatty acids in heart transplant recipients. J Am Coll Cardiol 1997; 29:1324-1331.
63. Ziboh VA. The significance of polyunsaturated fatty acids in cutaneous biology. Lipids 1996; 31 (Suppl):S249-S253.
64. Grimminger F, Mayser P. Lipid mediators, free fatty acids and psoriasis. Prostaglandins Leukot Essent Fatty Acids 1995; 52:1-15.
65. Chapkin RS, Ziboh VA. Inability of skin enzyme preparation to biosynthesize arachidonic acid from linoleic acid. Biochem Biophys Res Commun 1984; 124:784-792.
66. Mayser P, Arenberger P, Bartak P, Buchvald J, Christophers E, Jablonska S, et al. N-3 fatty acid-based lipid infusion in patients with chronic plaque psoriasis: result of a double-blind, randomized, placebo-controlled multicenter trial. J Am Acad Dermatol (in press). This is the first multicenter study to show the impact of intravenous lipid therapy in psoriasis.
67. Mayser P, Grimminger F, Papavassilis C, Schlotzer E, Seeger W. Reproducible effects of intravenously administered fish oil in acute relapsing psoriasis. J Dermatol Treat 1996; 7:211-214.
68. Fritsche KL, Shahbazian LM, Feng C, Berg JN. Dietary fish oil reduces survival and impairs bacterial clearance in c3h/hen mice challenged with Listeria monocytogenes. Clin Sci 1997; 92:95-101.
69. Blok WL, Debruijn MFTR, Leenen PJM, Eling WMC, Vanrooijen N, Stanley ER, et al. Dietary n-3 fatty acids increase spleen size and postendotoxin circulating TNF in mice: role of macrophages, macrophage precursors, and colony stimulating factor 1. J Immunol 1996; 157:5569-5573. This study shows the relation between increased circulating levels of TNF-α after lipopolysaccharide challenge and murine macrophages after FO supplementation.
70. Bower RH, Cerra FB, Bershadsky B, Licari JJ, Hoyt DB, Jensen GL, et al. Early enterai administration of a formula (Impact®) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, randomized, clinical trial. Crit Care Med 1995; 23:436-449.